Menstrual migraine: an updated review on hormonal causes, prophylaxis and treatment

被引:23
作者
Silberstein, Stephen [1 ]
Patel, Sumit [1 ]
机构
[1] Jefferson Headache Ctr, Philadelphia, PA 19107 USA
关键词
estrogen; menstrual; migraine; treatment; SHORT-TERM PROPHYLAXIS; MILD-PAIN PHASE; DOUBLE-BLIND; INTERMITTENT PROPHYLAXIS; ORAL ZOLMITRIPTAN; NAPROXEN SODIUM; EFFICACY; PREVENTION; FROVATRIPTAN; SUMATRIPTAN;
D O I
10.1517/14656566.2014.947959
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: In this article, we will discuss pure menstrual migraine without aura (PMM) and menstrually related migraine without aura (MRM). Depending on the frequency and severity of their attacks, patients with PMM will likely need an acute treatment and/or short-term preventive plan. Of note, with the use of acute treatments and short-term preventive therapy there is risk of medication overuse if the patient does have pure menstrual migraine and is being treated for menstrually related migraine. Areas covered: A PubMed, Cochrane Central, Medline, Ovid search provided articles relating to menstrual migraine pathophysiology and treatment. Expert opinion: Long-term daily preventive treatment should be considered for patients with MRM and those with severe PMM. Miniprophylaxis can be used in PMM rather than daily preventive treatment. When considering the use of short-term miniprophylaxis, sumatriptan, zolmitriptan, naratriptan, and frovatriptan have shown efficacy; however, frovatriptan appears to be the triptan of choice based on overall efficacy. Oral contraceptives may be considered if patients do not respond to or cannot tolerate typical migraine preventive medications. In patients with migraine with aura, oral contraceptives should be used with caution as this may add to the risk of stroke in this population.
引用
收藏
页码:2063 / 2070
页数:8
相关论文
共 50 条
[21]   Acute and preventive treatment of menstrual migraine: a meta-analysis [J].
Khoo, Cindy Ciat-Wuah ;
Liu, Chan-Cheng ;
Lu, Michael ;
Huang, Yu-Chen ;
Weng, Hsing-Yu .
JOURNAL OF HEADACHE AND PAIN, 2024, 25 (01)
[22]   The efficacy and tolerability of anticonvulsants in the prophylaxis of migraine: an updated systematic review [J].
Chronicle, EP ;
Mulleners, WM .
CEPHALALGIA, 2005, 25 (10) :945-946
[23]   Tonabersat for Migraine Prophylaxis: A Systematic Review [J].
Cao, Yue ;
Zheng, Ou Jin .
PAIN PHYSICIAN, 2014, 17 (01) :1-7
[24]   Triptans in prevention of menstrual migraine: a systematic review with meta-analysis [J].
Hu, Yong ;
Guan, Xiaofei ;
Fan, Lin ;
Jin, Lingjing .
JOURNAL OF HEADACHE AND PAIN, 2013, 14
[25]   A Cyclic Pain: The Pathophysiology and Treatment of Menstrual Migraine [J].
Mathew, Paul G. ;
Dun, Erica C. ;
Luo, Jin Jun .
OBSTETRICAL & GYNECOLOGICAL SURVEY, 2013, 68 (02) :130-140
[26]   Preventive treatment of menstrual migraine [J].
Lay C.L. ;
Broner S.W. .
Current Pain and Headache Reports, 2007, 11 (3) :227-230
[27]   Prevention and Treatment of Menstrual Migraine [J].
E. Anne MacGregor .
Drugs, 2010, 70 :1799-1818
[28]   Repurposed versus disease-specific medicinals for the prophylaxis of migraine: an updated systematic review [J].
Christofilos, Savvas-Ilias ;
Mavridis, Theodoros ;
Gkotzamanis, Viktor ;
Vasilopoulou, Sofia ;
Deligianni, Christina I. ;
Dimos-Dimitrios, Mitsikostas .
PAIN MANAGEMENT, 2025, 15 (07) :425-439
[29]   Safety and Tolerability of Frovatriptan in the Acute Treatment of Migraine and Prevention of Menstrual Migraine: Results of a New Analysis of Data From Five Previously Published Studies [J].
MacGregor, E. Anne ;
Pawsey, Stephen P. ;
Campbell, John C. ;
Hu, Xiaojun .
GENDER MEDICINE, 2010, 7 (02) :88-108
[30]   Prophylaxis of migraine headaches with riboflavin: A systematic review [J].
Thompson, D. F. ;
Saluja, H. S. .
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (04) :394-403